SOLENO THERAPEUTICS, INC.
SOLENO THERAPEUTICS, INC. is a registered legal entity registered in United States under 2178585, and its current status with California Secretary of State — bizfile Online is active. The company was incorporated on 7 October 1999 and lists its registered address as REDWOOD CITY, United States. 4 shareholders are on record for SOLENO THERAPEUTICS, INC., including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from California Secretary of State — bizfile Online and was last updated on 5 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
4
Four shareholders are currently on record for SOLENO THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Vanguard Group Inc, holding 6.5% — the largest recorded stake — followed by Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total at 2.1%; the remaining 2 shareholders shown hold smaller stakes.
3 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Vanguard Group Inc | 6.5% | California Secretary of State — bizfile Online | |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 2.1% | California Secretary of State — bizfile Online | |
| Fidelity Securities Fund-Fidelity OTC Portfolio | 2% | California Secretary of State — bizfile Online | |
| T. Rowe Price Health Sciences Fund, Inc. | 1.5% | California Secretary of State — bizfile Online |
Officers
5
The President, Ceo, Coo & Director of SOLENO THERAPEUTICS, INC. currently on record is Anish Bhatnagar M.d.; five officers are currently on record for SOLENO THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online.
The register reports 21 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at SOLENO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
SOLENO THERAPEUTICS, INC. sits 1 level below its ultimate parent, Neurocrine Biosciences, Inc., registered in United States. 3 subsidiaries are recorded beneath it, across 3 jurisdictions. The full chain up to Neurocrine Biosciences, Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by SOLENO THERAPEUTICS, INC.'s own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 3 subsidiaries span United States, United Kingdom, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Neurocrine Biosciences, Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns SOLENO THERAPEUTICS, INC.?
Four shareholders are currently on record for SOLENO THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Vanguard Group Inc, holding 6.5% — the largest recorded stake — followed by Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total at 2.1%; the remaining 2 shareholders shown hold smaller stakes. 3 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 1 is recorded as direct individual holder, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is SOLENO THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for SOLENO THERAPEUTICS, INC. is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does SOLENO THERAPEUTICS, INC. have on record?
4 shareholders are shown on record for SOLENO THERAPEUTICS, INC..
What is SOLENO THERAPEUTICS, INC.'s company registration number?
SOLENO THERAPEUTICS, INC.'s registration number is 2178585, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is SOLENO THERAPEUTICS, INC. still an active company?
SOLENO THERAPEUTICS, INC.'s status on California Secretary of State — bizfile Online is listed as active.
When was SOLENO THERAPEUTICS, INC. incorporated?
SOLENO THERAPEUTICS, INC. was incorporated on 7 October 1999, according to California Secretary of State — bizfile Online.
What is SOLENO THERAPEUTICS, INC.'s registered address?
The registered address on file for SOLENO THERAPEUTICS, INC. is REDWOOD CITY, United States.
Who are the officers/directors of SOLENO THERAPEUTICS, INC.?
The President, Ceo, Coo & Director of SOLENO THERAPEUTICS, INC. currently on record is Anish Bhatnagar M.d.; five officers are currently on record for SOLENO THERAPEUTICS, INC., filed with California Secretary of State — bizfile Online. Management authority at SOLENO THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does SOLENO THERAPEUTICS, INC. have a parent company or subsidiaries?
SOLENO THERAPEUTICS, INC. sits 1 level below its ultimate parent, Neurocrine Biosciences, Inc., registered in United States. 3 subsidiaries are recorded beneath it, across 3 jurisdictions. Those 3 subsidiaries span United States, United Kingdom, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to SOLENO THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to SOLENO THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access SOLENO THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like SOLENO THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 5 October 2026.